BioNexus Gene Lab Corp (BGLC) NPV

Sell:$0.41Buy:$0.42$0.00 (0.97%)

Prices delayed by at least 15 minutes
Sell:$0.41
Buy:$0.42
Change:$0.00 (0.97%)
Prices delayed by at least 15 minutes
Sell:$0.41
Buy:$0.42
Change:$0.00 (0.97%)
Prices delayed by at least 15 minutes

Company Information

About this company

BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.

Key people

Min Fong Yeat
Chairman of the Board
Lee Su-Leng Tan
President, Chief Executive Officer, Acting Chief Financial Officer, Chief Operating Officer
Chi Yuen Leong
Director
Meng Wong Yee
Director
Jook Yuen Low
Independent Director
Teong Teoh Boon
Independent Non-Executive Director
Ping Lin Chai
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Malaysia
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US0906282076
  • Market cap
    $7.19m
  • Employees
    30
  • Shares in issue
    17.97m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.